Skip to main content
Premium Trial:

Request an Annual Quote

Karin Eastham, Robert Brown, Marsha Fanucci, Kenneth Bate, Patti Doherty, Steve Lombardi, Leslie Brown, R.B. Woodward

Premium

Illumina has appointed Karin Eastham to its board of directors. She is currently executive vice president, chief operating officer, and a member of the board of trustees of the Burnham Institute. She is also a director of Tercica, Oncosis/Cyntellect, and Salmedix. Eastham received a BS and MBA from Indiana University.


Serologicals has hired Robert Brown as vice president of corporate development. Brown comes to Serologicals from Andrx, where he was senior vice president for corporate development. He has a BS in chemistry from Neumann College.


Millennium Pharmaceuticals has promoted Marsha Fanucci, senior vice president of finance and corporate strategy, to senior vice president and chief financial officer.

Fanucci will still oversee corporate strategy, the treasury, and financial planning and reporting, and will also be responsible for information technology at the company.

She succeeds Kenneth Bate, executive vice president and head of commercial operations, who will continue to report to the CEO. He will also oversee commercial manufacturing and quality assurance at Millennium.

Fanucci joined Millennium in 2000 from Genzyme, where she was a vice president for corporate development and strategy. She has a BS in pharmacy from West Virginia University and an MBA from Northeastern University.


Exagen Diagnostics has hired Patti Doherty as director of clinical studies, a newly created position. Doherty, a registered nurse, will run research and development of Exagen’s gene-based prognostic tests.


IntegraGen has named Steve Lombardi non-executive director, the company said. Lombardi is currently senior vice president of corporate development at Affymetrix, and spent 16 years at Applied Biosystems, where he rose to become senior vice president of applications and products.


Pharmacopeia Drug Discovery has named Leslie Brown as president and chief executive officer, the company announced last week.

Most recently, Brown served as chief operating officer at Iconix Pharmaceuticals. He has also been the chief operating officer at functional genomics company GeneTrace. From 1990 to 2000, Brown held a number of senior positions at Berlex/Schering AG including corporate vice president of Berlex Labs and president of Schering Berlin Venture.

Brown received his PhD from the University of Michigan, and was an NIH postdoctoral fellow at Harvard with Nobel laureate professor R.B. Woodward.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.